AU Patent

AU2017291812B2 — Bicyclic urea kinase inhibitors and uses thereof

Assigned to General Hospital Corp · Expires 2023-12-14 · 2y expired

What this patent protects

The present disclosure provides compounds of Formula (I), (II), and (III). The provided compounds are able to bind protein kinases (

USPTO Abstract

The present disclosure provides compounds of Formula (I), (II), and (III). The provided compounds are able to bind protein kinases (

Drugs covered by this patent

Patent Metadata

Patent number
AU2017291812B2
Jurisdiction
AU
Classification
—
Expires
2023-12-14
Drug substance claim
No
Drug product claim
No
Assignee
General Hospital Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.